Skip to main content

Table 2 Products in shortage with an overall rate on patient impact of 36 or higher

From: Medicine shortages: impact behind numbers

Product

Product characteristics

Rates on the elements of patient impact (rating 1 = low, 2 = moderate, 3 = high)

Overall score

 

ATC class

Route of administration

Originator or generic

Alternative product

Disease

Susceptibility

Costs

Number of patients

 

BCG instillation

L

Parenteral

Originator

2

3

3

2

2

72

Risperidone orodispersible tablet

N

Oral

Originator

2

3

3

3

1

54

Epinephrine injection

C

Parenteral

Originator

2

3

2

2

2

48

Methoxy polyethylene glycol-epoetin beta injection

B

Parenteral

Originator

2

2

2

3

2

48

Bendamustine powder for infusion

L

Parenteral

Originator

2

3

1

3

2

36

Bromperidol drops for oral use

N

Oral

Originator

2

3

3

2

1

36

Dexamethasone tablet

H

Oral

Generic

2

3

1

3

2

36

Disulfiram dispersible tablet

N

Oral

Originator

2

3

2

3

1

36

Feneticilline capsule

J

Oral

Originator

2

2

1

3

3

36

Flupentixol tablet

N

Oral

Originator

2

3

3

2

1

36

Ibuprofen granules

M

Oral

Originator

2

3

1

2

3

36

Isosorbide mononitrate sustained tablet

C

Oral

Originator

2

3

1

3

2

36

Lamotrigine dispersible tablet

N

Oral

Generic

2

3

2

3

1

36

Olanzapine orodispersible tablet

N

Oral

Generic

2

3

3

2

1

36

Pergolide tablet

N

Oral

Generic

2

3

2

3

1

36

Topiramate tablet

N

Oral

Generic

2

3

2

3

1

36

Vincristine sulfate injection

L

Parenteral

Generic

2

3

1

3

2

36